Speciality Generic Injectables

Narender Dev Mantena

Head, Global Strategy & CEO, Specialty Generic Injectables & Synthetic Biology

Narender Mantena has been associated with Biological E. Limited since 1992. He has been responsible for forging key alliances with GSK, Merck and Intercell. He laid the road map for the company’s foray into the regulated markets. He also championed the complex/routine injectables, novel vaccines and synthetic biology initiatives at Biological E. Limited. Narender Mantena holds a Master’s Degree in Engineering from Michigan State University.

Madhusudan Rao

COO, Specialty Generic Injectables

Madhusudan Rao has more than two decades of pharmaceutical experience in Product Selection, Development, Manufacturing, Quality, Regulatory and Marketing. Prior to joining Biological E. Limited in 2016, Madhu was P&L Head at Orchid & Granules India. He also worked for 17 years at Dr. Reddy’s Laboratories Limited holding roles of increasing responsibility. Madhu holds an MSc. and an M.Phil in Chemistry from the University of Hyderabad.

Bill Hill

President

Bill brings more than 20 years of generic and brand pharma experience to BE Pharmaceuticals Inc. Bill was part of the successful US market entry with Endo, Dr. Reddy’s and Alvogen. Leading the commercial team at Alvogen, the group won 6 consecutive HDMA awards as top supplier and multiple large customer best-in-class awards. Bill is President, US Commercial Operations of BE Pharmaceuticals Inc. Bill has a Bachelor’s Degree in Business / Marketing from the University of Lynchburg.

Speciality Generic Injectables

Narender Dev Mantena

Head, Global Strategy &
CEO, Specialty Generic Injectables
& Synthetic Biology

Narender Mantena has been associated with Biological E. Limited since 1992. He has been responsible for forging key alliances with GSK, Merck and Intercell. He laid the road map for the company’s foray into the regulated markets. He also championed the complex/routine injectables, novel vaccines and synthetic biology initiatives at Biological E. Limited. Narender Mantena holds a Master’s Degree in Engineering from Michigan State University.
Madhusudan Rao

COO, Speciality Generic Injectables

Madhusudan Rao has more than two decades of pharmaceutical experience in Product Selection, Development, Manufacturing, Quality, Regulatory and Marketing. Prior to joining Biological E. Limited in 2016, Madhu was P&L Head at Orchid & Granules India. He also worked for 17 years at Dr. Reddy’s Laboratories Limited holding roles of increasing responsibility. Madhu holds an MSc. and an M.Phil in Chemistry from the University of Hyderabad.
Bill Hill

President

Bill brings more than 20 years of generic and brand pharma experience to BE Pharmaceuticals Inc. Bill was part of the successful US market entry with Endo, Dr. Reddy’s and Alvogen. Leading the commercial team at Alvogen, the group won 6 consecutive HDMA awards as top supplier and multiple large customer best-in-class awards. Bill is President, US Commercial Operations of BE Pharmaceuticals Inc. Bill has a Bachelor’s Degree in Business / Marketing from the University of Lynchburg.
×
Narender Dev Mantena

Narender Dev Mantena

Narender Mantena has been associated with Biological E. Limited since 1992. He has been responsible for forging key alliances with GSK, Merck and Intercell. He laid the road map for the company’s foray into the regulated markets. He also championed the complex/routine injectables, novel vaccines and synthetic biology initiatives at Biological E. Limited. Narender Mantena holds a Master’s Degree in Engineering from Michigan State University.

×
Madhusudan Rao

Madhusudan Rao

Madhusudan Rao has more than two decades of pharmaceutical experience in Product Selection, Development, Manufacturing, Quality, Regulatory and Marketing. Prior to joining Biological E. Limited in 2016, Madhu was P&L Head at Orchid & Granules India. He also worked for 17 years at Dr. Reddy’s Laboratories Limited holding roles of increasing responsibility. Madhu holds an MSc. and an M.Phil in Chemistry from the University of Hyderabad.

×
Sudhakar Vadapalli

Bill Hill

Bill brings more than 20 years of generic and brand pharma experience to BE Pharmaceuticals Inc. Bill was part of the successful US market entry with Endo, Dr. Reddy’s and Alvogen. Leading the commercial team at Alvogen, the group won 6 consecutive HDMA awards as top supplier and multiple large customer best-in-class awards. Bill is President, US Commercial Operations of BE Pharmaceuticals Inc. Bill has a Bachelor’s Degree in Business / Marketing from the University of Lynchburg.

×

The information on this website is intended for use only by residents of the United States of America. The product information on this site is provided for general information purposes only and is not intended to be a substitute for the actual approved product information. This information is neither medical advice nor a substitute for discussions with a qualified medical professional. The products listed are available only through prescription by a qualified medical professional. BE Pharmaceuticals Inc. and its affiliates shall not be responsible for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing.

I AgreeI Decline